As we wrap up 2025, we’re taking a moment to reflect and to say thank you. This year marked a turning point for human-relevant science. The FDA’s NAMs roadmap, NIH’s Standardized Organoid Modeling Center, and FDA Modernization Act 3.0 all pointed in the same direction: preclinical research is shifting closer to human biology. We’re proud to be part of that shift.
To celebrate the season, we’re offering up to 30% off our organoid services and assays for orders placed before February 28, 2026. We hope this helps you stretch your research budget further while advancing your goals.
At Lambda Biologics, our mission stayed focused – developing organoid platforms that make translational research more predictive and reproducible. From adult tissue and PSC-derived models to patient-specific cancer systems and tumor microenvironment co-cultures, we’ve worked to ensure every platform meets the standards researchers need.
2025 Milestones
- Recognition from the BioTech Breakthrough Awards
- Being featured in a Nature special issue on organoid and animal-free innovation
- Distributing Stress-Induced Hair Greying Model Using Human Skin Organoids, which won the 2025 IFSCC Basic Research Award – a product developed in collaboration with OrganoidSciences
- Supporting researchers globally with regulatory-ready organoid platforms
- Collaborations across the US, EU, and ASEAN.
None of this happens without the scientists, collaborators, and advocates pushing for more ethical and effective research models. Thank you for being part of this journey.
Here’s to a year of groundbreaking discoveries, reproducible science, and meaningful impact on patient outcomes. May this festive season bring you joy, peace, and inspiration for the discoveries that lie ahead in the New Year.
Warm regards,
Lambda Biologics Team
Unlocking Human Insight with Organoid Models
Lambda Biologics provides advanced organoid technology and services for biomedical research and drug development. We specialize in physiologically relevant 3D organoid models that bridge the gap between traditional cell cultures and animal models.
Our comprehensive solutions span disease modeling, drug screening, personalized medicine, and regulatory-compliant testing – supporting pharmaceutical companies, biotech firms, academic institutions, and cosmetics manufacturers worldwide.
Cerebral Organoid | Midbrain Organoid | Skin & Hair Organoid | Intestine Organoid | Gastric Cancer Organoid | Breast Cancer Organoid | Hepatocarcinoma Cancer Organoid | Pancreatic Cancer Organoid
